| Matthew Hutt Group, Llc | |
|
2208 Broadway Scottsbluff NE 69361-1970 | |
| (308) 632-8080 | |
| (308) 632-8084 |
| Full Name | Matthew Hutt Group, Llc |
|---|---|
| Speciality | Psychologist |
| Location | 2208 Broadway, Scottsbluff, Nebraska |
| Authorized Official Name and Position | Matthew Martin Hutt (OWNER) |
| Authorized Official Contact | 3086328080 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Hutt Group, Llc 2208 Broadway Scottsbluff NE 69361-1970 Ph: (308) 632-8080 | Matthew Hutt Group, Llc 2208 Broadway Scottsbluff NE 69361-1970 Ph: (308) 632-8080 |
| NPI Number | 1073817128 |
|---|---|
| Provider Enumeration Date | 01/04/2011 |
| Last Update Date | 01/04/2011 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073817128 | NPI | - | NPPES |
| 10025917000 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 9244 (Nebraska) | Secondary |
| 103T00000X | Psychologist | 331 (Nebraska) | Primary |
| 103T00000X | Psychologist | 393 (Nebraska) | Secondary |
News Archive
Outcome Sciences, Inc., the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, and REACH Call, the leading provider of web-based telemedicine services, today announced a partnership to integrate stroke-telemedicine data into the American Heart Association's Get With The Guidelines®–Stroke program.
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced preliminary results for two phase III trials evaluating Prochymal for the treatment of acute graft versus host disease (GvHD). GvHD, the most common complication of bone marrow transplantation, is a life-threatening disease for which there is currently no approved treatment. Prochymal showed significant improvements in response rates in difficult-to-treat liver and gastrointestinal GvHD, however neither trial reached its primary endpoint.
The Alzheimer's Association today called on the House of Representatives to provide $40 million in additional funding this year to the National Institutes of Health NIH) to support large-scale clinical trials for treatments that would slow or delay the progression of Alzheimer's disease.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
› Verified 6 days ago
Donald E. Fischer, Md, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 W Railway St, Scottsbluff, NE 69361 Phone: 308-632-0800 | |
Educational Service Unit 13 Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4215 Avenue I, Scottsbluff, NE 69361 Phone: 308-635-3696 | |
Sober Mind Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1502 2nd Ave Ste 3, Scottsbluff, NE 69361 Phone: 308-633-4314 Fax: 308-633-9505 | |
Options In Psychology Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2622 Avenue C, Scottsbluff, NE 69361 Phone: 308-632-8547 Fax: 308-632-0135 | |
Samuel Crouch Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 W Railway St Ste A102, Scottsbluff, NE 69361 Phone: 308-225-0500 Fax: 308-365-6848 | |
Forward Thinking Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2621 5th Ave Ste 4, Scottsbluff, NE 69361 Phone: 308-230-0736 |